Segment Reporting and Foreign Operations (Tables)

12 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Revenue from External Customers by Products and Services

Listed below are the sales by business segment for the years ended December 31, 2016, 2015 and 2014 (in thousands):

	% Change	2016		% Change	2015		% Change	2014
Cardiovascular
Stand-alone devices	25%	$	193,517	8%	$	155,414	15%	$	143,712
Custom kits and procedure trays	3%	119,392		5%	116,368		7%	111,076
Inflation devices	1%	73,919		1%	73,373		10%	72,538
Catheters	15%	110,939		11%	96,833		17%	87,550
Embolization devices	2%	46,035		3%	45,025		31%	43,855
CRM/EP	8%	36,446		3%	33,902		17%	32,975
Total	11%	580,248		6%	520,915		14%	491,706
Endoscopy
Endoscopy devices	11%	23,590		18%	21,234		6%	17,983
Total	11%	$	603,838	6%	$	542,149	14%	$	509,689

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas

Our long-lived assets by geographic area at December 31, 2016, 2015 and 2014, consisted of the following (in thousands):

	2016		2015		2014
United States	$	194,715	$	186,389	$	177,627
Ireland	47,337		48,896		49,708
Other foreign countries	34,521		32,493		16,836
Total	$	276,573	$	267,778	$	244,171

Schedule of Segment Reporting Information, by Segment

Total depreciation and amortization by business segment for the years ended December 31, 2016, 2015, and 2014 consisted of the following (in thousands):

	2016		2015		2014
Cardiovascular	$	42,806	$	36,474	$	34,975
Endoscopy	949		951		954
Total	$	43,755	$	37,425	$	35,929

Total capital expenditures for property and equipment by business segment for the years ended December 31, 2016, 2015 and 2014 consisted of the following (in thousands):

	2016		2015		2014
Cardiovascular	$	32,613	$	50,927	$	33,660
Endoscopy	224		32		521
Total	$	32,837	$	50,959	$	34,181

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2016, 2015 and 2014, are as follows (in thousands):

	2016			2015			2014
Net Sales
Cardiovascular	$	580,248		$	520,915		$	491,706
Endoscopy	23,590			21,234			17,983
Total net sales	603,838			542,149			509,689
Operating expenses
Cardiovascular	218,659			187,492			175,152
Endoscopy	11,490			10,746			9,904
Total operating expenses	230,149			198,238			185,056
Operating income (loss)
Cardiovascular	30,120			34,052			38,601
Endoscopy	4,756			3,491			1,565
Total operating income	34,876			37,543			40,166
Total other expense - net	(9,490		)	(6,343		)	(8,594		)
Income tax expense	5,265			7,398			8,598
Net income	$	20,121		$	23,802		$	22,974

Reconciliation of Assets from Segment to Consolidated

Total assets by business segment at December 31, 2016, 2015 and 2014, consisted of the following (in thousands):

	2016		2015		2014
Cardiovascular	$	932,927	$	767,952	$	734,940
Endoscopy	9,876		10,776		12,225
Total	$	942,803	$	778,728	$	747,165